Latest Commercialisation News

INOVIQ Limited reports strong clinical validation for its EXO-OC ovarian cancer screening test and promising preclinical results for CAR-exosome therapeutics targeting aggressive cancers.

Bass Oil Limited reported a 4% rise in June oil production alongside advancing plans to acquire the Vanessa gas field, signaling a strategic pivot towards gas sales and resource expansion.

Archer Materials advances its quantum computing and medical diagnostics technologies, extending key partnerships and forming a new advisory board while maintaining a strong cash position to fuel development.

Proteomics International’s subsidiary OxiDx has unveiled a pioneering test that detects muscle damage in thoroughbred racehorses, promising to transform recovery management in the racing industry. The test’s commercial launch is slated for the second half of 2025.

InteliCare has launched a three-month trial of its AI-powered platform at mecwacare’s Trescowthick Centre, marking a significant step in its commercialisation strategy with a leading aged care provider.

BMG Resources confirms a substantial gold system at its Abercromby Gold Project through Phase 1 drilling results, validating its geological model and setting the stage for resource expansion. The company is advancing plans for Phase 2 drilling and a scoping study to explore commercial mining potential.

Tissue Repair Limited has secured major distribution partnerships in Australia, New Zealand, and Thailand for its TR Pro+® product line, marking a pivotal shift from development to commercialisation. The company is also scaling up manufacturing and advancing regulatory approvals to support its global expansion ambitions.

Sunshine Metals has completed resource infill drilling at its Plateau gold-silver prospect and reconnaissance drilling at the Salla gold-copper-zinc prospect, delivering results that support an upcoming resource update and further exploration.

Nanoveu Limited has raised A$2 million through a strategic placement to accelerate the commercialisation of its 16nm ECS-DoT chip and expand its EMASS modular AIoT platform, positioning the company for global growth.

Buru Energy has agreed to sell its hydrogen-focused subsidiary 2H Resources and non-core Canning Basin assets to Koloma Australia for up to AUD 2 million, marking a strategic pivot towards its Rafael Gas Project.

Echo IQ has secured a pivotal reseller agreement with US-based SARC MedIQ, unlocking access to over 300 healthcare facilities and accelerating adoption of its AI-driven EchoSolv AS technology across the American cardiology landscape.

Orthocell has achieved a significant milestone by recording its first US sales revenue for Remplir™, its flagship nerve repair product, shortly after FDA clearance and initial surgical use.